Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Raw Materials (2023 - 2025)

Historic Raw Materials for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $2.5 million.

  • Profound Medical's Raw Materials changed N/A to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is 1646.11% down from last year.
  • Profound Medical's Raw Materials amounted to $2.5 million in Q3 2025.
  • Over the past 5 years, Profound Medical's Raw Materials peaked at $2.7 million during Q2 2025, and registered a low of $2.0 million during Q4 2024.
  • For the 3-year period, Profound Medical's Raw Materials averaged around $2.3 million, with its median value being $2.4 million (2023).
  • Data for Profound Medical's Raw Materials shows a peak YoY increase of 1646.11% (in 2024) and a maximum YoY decrease of 1646.11% (in 2024) over the last 5 years.
  • Over the past 3 years, Profound Medical's Raw Materials (Quarter) stood at $2.4 million in 2023, then dropped by 16.46% to $2.0 million in 2024, then increased by 26.99% to $2.5 million in 2025.
  • Its Raw Materials stands at $2.5 million for Q3 2025, versus $2.7 million for Q2 2025 and $2.2 million for Q1 2025.